Exercise program aims to boost recovery in older transplant patients
NCT ID NCT05612789
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a supervised exercise program can improve recovery and survival in people aged 60 and older receiving a stem cell transplant for blood cancer. Participants will exercise before and after their transplant, with compliance tracked by activity monitors. The main goal is to see if the program is feasible, with secondary goals including hospital stay length and survival rates.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- supervised exercise program
- What this could lead to
- If it works, this could show that exercise helps older transplant patients recover faster and have better long-term outcomes.
- What could go wrong
- This is a small pilot study focused on feasibility, not proof of benefit. Results may not apply to all patients, and exercise may be difficult for some.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLOGENEIC TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Penn Medicine
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a walk a day keep brain fog away after a stem cell transplant?
- Ancient herb, modern hope: ashwagandha compound tested to prevent deadly transplant complication
- Ancient herb takes on transplant complication: Withaferin-A tested for Steroid-Resistant GVHD
- New program helps caregivers of stem cell patients cope better
- New antibiotic could shield blood cancer patients from deadly infections
- Can a common asthma drug stop post-transplant fevers?